176 related articles for article (PubMed ID: 9094685)
1. Potent inhibition of human immunodeficiency virus type 1 in primary T cells and alveolar macrophages by a combination anti-Rev strategy delivered in an adeno-associated virus vector.
Inouye RT; Du B; Boldt-Houle D; Ferrante A; Park IW; Hammer SM; Duan L; Groopman JE; Pomerantz RJ; Terwilliger EF
J Virol; 1997 May; 71(5):4071-8. PubMed ID: 9094685
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain.
Lee SW; Gallardo HF; Gilboa E; Smith C
J Virol; 1994 Dec; 68(12):8254-64. PubMed ID: 7966618
[TBL] [Abstract][Full Text] [Related]
3. Transduction of human CD34+ hematopoietic progenitor cells by a retroviral vector expressing an RRE decoy inhibits human immunodeficiency virus type 1 replication in myelomonocytic cells produced in long-term culture.
Bahner I; Kearns K; Hao QL; Smogorzewska EM; Kohn DB
J Virol; 1996 Jul; 70(7):4352-60. PubMed ID: 8676458
[TBL] [Abstract][Full Text] [Related]
4. Transient protection of human T-cells from human immunodeficiency virus type 1 infection by transduction with adeno-associated viral vectors which express RNA decoys.
Smith C; Lee SW; Wong E; Gallardo H; Page K; Gaspar O; Lebkowski J; Gilboa E
Antiviral Res; 1996 Oct; 32(2):99-115. PubMed ID: 8891169
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of human immunodeficiency virus-1 (HIV-1) replication after transduction of granulocyte colony-stimulating factor-mobilized CD34+ cells from HIV-1-infected donors using retroviral vectors containing anti-HIV-1 genes.
Bauer G; Valdez P; Kearns K; Bahner I; Wen SF; Zaia JA; Kohn DB
Blood; 1997 Apr; 89(7):2259-67. PubMed ID: 9116267
[TBL] [Abstract][Full Text] [Related]
6. Intracellular inhibition of HIV-1 replication using a dual protein- and RNA-based strategy.
Duan L; Zhu M; Ozaki I; Zhang H; Wei DL; Pomerantz RJ
Gene Ther; 1997 Jun; 4(6):533-43. PubMed ID: 9231069
[TBL] [Abstract][Full Text] [Related]
7. Intracellular immunization against HIV-1 infection of human T lymphocytes: utility of anti-rev single-chain variable fragments.
Duan L; Zhu M; Bagasra O; Pomerantz RJ
Hum Gene Ther; 1995 Dec; 6(12):1561-73. PubMed ID: 8664381
[TBL] [Abstract][Full Text] [Related]
8. Defective lentiviral vectors are efficiently trafficked by HIV-1 and inhibit its replication.
Klimatcheva E; Planelles V; Day SL; Fulreader F; Renda MJ; Rosenblatt J
Mol Ther; 2001 Jun; 3(6):928-39. PubMed ID: 11407907
[TBL] [Abstract][Full Text] [Related]
9. A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAs, and trans-dominant negative mutant Gag and Env proteins.
Ding SF; Lombardi R; Nazari R; Joshi S
Front Biosci; 2002 Feb; 7():a15-28. PubMed ID: 11815282
[TBL] [Abstract][Full Text] [Related]
10. Expression of a protective gene-prolongs survival of T cells in human immunodeficiency virus-infected patients.
Woffendin C; Ranga U; Yang Z; Xu L; Nabel GJ
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2889-94. PubMed ID: 8610137
[TBL] [Abstract][Full Text] [Related]
11. Continuous propagation of RRE(-) and Rev(-)RRE(-) human immunodeficiency virus type 1 molecular clones containing a cis-acting element of simian retrovirus type 1 in human peripheral blood lymphocytes.
Zolotukhin AS; Valentin A; Pavlakis GN; Felber BK
J Virol; 1994 Dec; 68(12):7944-52. PubMed ID: 7966585
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.
Mautino MR; Keiser N; Morgan RA
J Virol; 2001 Apr; 75(8):3590-9. PubMed ID: 11264348
[TBL] [Abstract][Full Text] [Related]
13. Decoy approach using RNA-DNA chimera oligonucleotides to inhibit the regulatory function of human immunodeficiency virus type 1 Rev protein.
Nakaya T; Iwai S; Fujinaga K; Sato Y; Otsuka E; Ikuta K
Antimicrob Agents Chemother; 1997 Feb; 41(2):319-25. PubMed ID: 9021186
[TBL] [Abstract][Full Text] [Related]
14. Antiviral potency of drug-gene therapy combinations against human immunodeficiency virus type 1.
Junker U; Baker J; Kalfoglou CS; Veres G; Kaneshima H; Böhnlein E
AIDS Res Hum Retroviruses; 1997 Nov; 13(16):1395-402. PubMed ID: 9359659
[TBL] [Abstract][Full Text] [Related]
15. Stable expression of transdominant Rev protein in human T cells inhibits human immunodeficiency virus replication.
Malim MH; Freimuth WW; Liu J; Boyle TJ; Lyerly HK; Cullen BR; Nabel GJ
J Exp Med; 1992 Oct; 176(4):1197-201. PubMed ID: 1402661
[TBL] [Abstract][Full Text] [Related]
16. Molecular and virological effects of intracellular anti-Rev single-chain variable fragments on the expression of various human immunodeficiency virus-1 strains.
Duan L; Zhang H; Oakes JW; Bagasra O; Pomerantz RJ
Hum Gene Ther; 1994 Nov; 5(11):1315-24. PubMed ID: 7893803
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human immunodeficiency virus type 1 replication in human T cells by retroviral-mediated gene transfer of a dominant-negative Rev trans-activator.
Bevec D; Dobrovnik M; Hauber J; Böhnlein E
Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9870-4. PubMed ID: 1409715
[TBL] [Abstract][Full Text] [Related]
18. The herpes simplex virus 1 Us11 protein cooperates with suboptimal amounts of human immunodeficiency virus type 1 (HIV-1) Rev protein to rescue HIV-1 production.
Duc Dodon M; Mikaélian I; Sergeant A; Gazzolo L
Virology; 2000 Apr; 270(1):43-53. PubMed ID: 10772978
[TBL] [Abstract][Full Text] [Related]
19. Constitutive expression of chimeric neo-Rev response element transcripts suppresses HIV-1 replication in human CD4+ T lymphocytes.
Bevec D; Volc-Platzer B; Zimmermann K; Dobrovnik M; Hauber J; Veres G; Böhnlein E
Hum Gene Ther; 1994 Feb; 5(2):193-201. PubMed ID: 8186299
[TBL] [Abstract][Full Text] [Related]
20. Combination gene therapy: synergistic inhibition of human immunodeficiency virus Tat and Rev functions by a single RNA molecule.
Lisziewicz J; Zeng G; Gratas C; Weinstein JN; Lori F
Hum Gene Ther; 2000 Apr; 11(6):807-15. PubMed ID: 10779158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
